SCHEMBL4853382

SCHEMBL4853382

CCc1ccc(Cc2ncccc2O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
KDM4E B2RXH2 1/20 0.49
HSD17B10 Q99714 2/20 0.45
CYP2C19 P33261 2/20 0.42
HIF1A Q16665 1/20 0.42
CHRM1 P11229 2/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM3 P20309 1/20 0.38
TRPA1 O75762 1/20 0.38
HSP90AA1 P07900 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
EGLN1 Q9GZT9 1/20 0.37
PAX8 Q06710 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1445774 0.83 KDM4E (0.51) ALDH1A1L3MBTL1KDM4EHSD17B10HIF1A
SCHEMBL1973913 0.83 KDM4E (0.68) ALDH1A1L3MBTL1KDM4EHSD17B10CYP2C19
Hydrochloric Acid SCHEMBL31388648 0.81 KDM4E (0.71) ALDH1A1L3MBTL1KDM4EHSD17B10CYP2C19
SCHEMBL31121578 0.81
SCHEMBL765054 0.81
SCHEMBL11018646 0.79 ALDH1A1 (0.50) ALDH1A1L3MBTL1KDM4EHSD17B10CYP2C19
SCHEMBL28147344 0.79 ALDH1A1 (0.46) ALDH1A1L3MBTL1KDM4EHSD17B10CYP2C19
SCHEMBL9696899 0.78 ALDH1A1 (0.49) ALDH1A1L3MBTL1KDM4EHSD17B10CYP2C19
SCHEMBL152665 0.75 PAX8 (0.41) ALDH1A1KDM4ECYP2C19CYP1A2CYP2D6
SCHEMBL21609587 0.75 L3MBTL1 (0.49) ALDH1A1L3MBTL1KDM4EHSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439232-B2 Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20060194809-A1 Heteroaryl 5-thio-beta-d-gucopyranoside derivatives and therapeutic agents for diabetes containing the same TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-08-31 US disclosed
EP-1609799-A1 HETEROARYL 5-THIO-BETA-D-GLUCOPYRANOSIDE DERIVATIVES AND REMEDIES FOR DIABETES CONTAINING THE SAME TAISHO PHARMACEUTICAL CO., LTD (JP) 2005-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194809-A1 Heteroaryl 5-thio-beta-d-gucopyranoside derivatives and therapeutic agents for diabetes containing the same SLC5A2, SLC5A1, UGGT1 ALDH1A1 815/4885L3MBTL1 3504/4885KDM4E 3958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.